These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1371569)

  • 41. Stanford experience with chemotherapy for metastatic prostate cancer.
    Torti FM; Reese J; Freiha F
    Prog Clin Biol Res; 1990; 350():171-85. PubMed ID: 1696740
    [No Abstract]   [Full Text] [Related]  

  • 42. Re: Gamma-seminoprotein--a new tumour marker in prostatic cancer?
    Scheit KH
    Br J Urol; 1991 Sep; 68(3):331-2. PubMed ID: 1717099
    [No Abstract]   [Full Text] [Related]  

  • 43. The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.
    Carter HB; Partin AW; Epstein JI; Chan DW; Walsh PC
    J Urol; 1990 Nov; 144(5):1167-70; discussion 1170-1. PubMed ID: 1700143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer.
    Seidman AD; Scher HI; Petrylak D; Dershaw DD; Curley T
    J Urol; 1992 Mar; 147(3 Pt 2):931-4. PubMed ID: 1371564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of biochemical bone metabolism parameters].
    Hegele A; Olbert P; Wahl HG; Hofmann R
    Urologe A; 2007 Sep; 46(9):1285-6. PubMed ID: 17609924
    [No Abstract]   [Full Text] [Related]  

  • 46. [Not Available].
    Obry AM
    Aktuelle Urol; 2016 Apr; 47(2):126-7. PubMed ID: 27078140
    [No Abstract]   [Full Text] [Related]  

  • 47. Seminal fluid: a useful source of prostate cancer biomarkers?
    Roberts MJ; Richards RS; Gardiner RA; Selth LA
    Biomark Med; 2015; 9(2):77-80. PubMed ID: 25689895
    [No Abstract]   [Full Text] [Related]  

  • 48. Screening for prostatic carcinoma with prostate specific antigen.
    Brawer MK; Chetner MP; Beatie J; Buchner DM; Vessella RL; Lange PH
    J Urol; 1992 Mar; 147(3 Pt 2):841-5. PubMed ID: 1371559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening for prostatic carcinoma.
    Hinman F
    J Urol; 1991 Jan; 145(1):126-9; discussion 129-30. PubMed ID: 1701495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostate-specific membrane antigen: current and future utility.
    Gregorakis AK; Holmes EH; Murphy GP
    Semin Urol Oncol; 1998 Feb; 16(1):2-12. PubMed ID: 9508077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate.
    Maatman TJ
    J Urol; 1989 Jun; 141(6):1378-80. PubMed ID: 2470927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Carcinoma of the prostate: correlation between local staging and systemic progression].
    Rosi P; Marzi M; Mearini E; Bracarda S; Valli PP; Petroni PA; Porena M
    Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):91-5. PubMed ID: 9162385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer.
    Mortarelli EA
    Ann Clin Lab Sci; 1992; 22(4):201-6. PubMed ID: 1380223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience].
    Mannini D; Aiello E; Maver P; Corrado G; Vecchi F; Bellanova B
    Minerva Urol Nefrol; 1987; 39(4):335-41. PubMed ID: 2453928
    [No Abstract]   [Full Text] [Related]  

  • 55. Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy.
    Link P; Freiha FS; Stamey TA
    J Urol; 1991 Mar; 145(3):532-4. PubMed ID: 1705294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostate specific antigen after irradiation for prostatic carcinoma.
    Kaplan I; Prestidge BR; Cox RS; Bagshaw MA
    J Urol; 1990 Nov; 144(5):1172-5; discussion 1175-6. PubMed ID: 1700144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.
    Hendriks RJ; van Oort IM; Schalken JA
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):12-19. PubMed ID: 27922627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in prostate-specific markers under chronic gonadotrophin-releasing hormone analogue treatment of state D prostatic cancer.
    Matzkin H; Lewyshon O; Ayalon D; Braf Z
    Cancer; 1989 Apr; 63(7):1287-91. PubMed ID: 2465816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
    Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
    Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer.
    Fawzy MS; Mohamed RH; Elfayoumi AR
    Med Oncol; 2015 Mar; 32(3):74. PubMed ID: 25698533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.